Abbott Laboratories Stock Bulgaria S.E.
Stocks
ABL
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.73 EUR | +7.63% |
|
0.00% | -30.19% |
| 09:22am | Abbott Laboratories, ALZpath Sign Global Licensing Deal for Alzheimer's Disease Diagnostic | MT |
| 07:35am | ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test | RE |
| Market Cap | 158B 139B 128B 120B 224B 14,863B 229B 1,539B 596B 7,332B 592B 579B 25,509B | P/E 2026 * |
22.8x | P/E 2027 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 169B 149B 138B 129B 241B 15,969B 246B 1,653B 640B 7,877B 636B 622B 27,406B | EV / Sales 2026 * |
3.37x | EV / Sales 2027 * | 3.04x |
| Free-Float |
86.73% | Yield 2026 * |
2.81% | Yield 2027 * | 3% |
Last Transcript: Abbott Laboratories
| 1 day | +7.63% | ||
| 1 month | +1.93% | ||
| 3 months | -24.71% | ||
| 6 months | -30.19% | ||
| Current year | -30.19% |
| 1 month | 74.08 | 74.44 | |
| Current year | 72.68 | 98.39 | |
| 1 year | 72.68 | 98.39 | |
| 3 years | 72.68 | 110.91 | |
| 5 years | 72.68 | 110.91 | |
| 10 years | 72.68 | 110.91 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 2023-08-31 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 2011-12-08 |
Daniel Starks
BRD | Director/Board Member | 71 | 2017-02-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +7.63% | 0.00% | - | - | 158B | ||
| -0.62% | +2.55% | -6.91% | -7.90% | 103B | ||
| -0.51% | -2.64% | +54.91% | +56.80% | 54.84B | ||
| +1.20% | +2.66% | -3.28% | +51.51% | 54.69B | ||
| +2.68% | +4.35% | -13.87% | -42.39% | 39.66B | ||
| +2.12% | -1.02% | - | - | 29.85B | ||
| +1.20% | -2.08% | -20.35% | -44.03% | 26.59B | ||
| +1.20% | +5.20% | +52.87% | -6.75% | 23.77B | ||
| -0.46% | -1.62% | -18.36% | -4.42% | 20.03B | ||
| +1.95% | +3.90% | -13.53% | -2.28% | 19.8B | ||
| Average | +1.65% | -2.50% | +3.93% | +0.07% | 41.38B | |
| Weighted average by Cap. | +2.74% | -2.21% | +4.81% | +5.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.29B 44.27B 40.84B 38.19B 71.56B 4,740B 72.9B 491B 190B 2,338B 189B 185B 8,135B | 54.79B 48.24B 44.5B 41.62B 77.97B 5,165B 79.43B 535B 207B 2,548B 206B 201B 8,864B |
| Net income | 7.02B 6.18B 5.7B 5.33B 9.99B 662B 10.17B 68.5B 26.53B 326B 26.35B 25.78B 1,135B | 8.39B 7.39B 6.82B 6.37B 11.94B 791B 12.17B 81.9B 31.72B 390B 31.51B 30.83B 1,358B |
| Net Debt | 11.73B 10.32B 9.52B 8.91B 16.69B 1,105B 17B 114B 44.33B 545B 44.03B 43.07B 1,897B | 8.88B 7.82B 7.21B 6.75B 12.64B 837B 12.88B 86.69B 33.58B 413B 33.35B 32.63B 1,437B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABL Stock
Select your edition
All financial news and data tailored to specific country editions


















